Pay Per View

Home / Pay Per View

Top News

FDA 483 Cites Quality Deficiencies at Indian Drug Plant
Patient Injured in Intellias Phase 3 nex-z Trial Dies
FDA OKs Darzalex Faspro for Smoldering Multiple Myeloma
Senate Democrats Caution FDA on Mifepristone Review
FDA Posts Biohaven Troriluzole Complete Response Letter
FDA Extends Review of Rhythms Setmelanotide sNDA
Baxter Oncology FDA-483 Out
76 New or Revised Product-Specific Guidances Out

<< Prev
715

Next >>

FDA Webview Free Daily e-Newsletter

Free Sign-Up

Dickinson's FDA Webview is the interactive Web site that watches the U.S. Food and Drug Administration all day long. From the leading publisher of FDA-content business newsletters since 1984, you can monitor regulatory, legal, policy and scientific news affecting all FDA-regulated healthcare products and their marketing activities.